Notwithstanding these limitations, disproportionality analysis still remains a crucial tool for detecting potential safety signals associated with drugs and guiding further investigations [Reference Chen, Ding, Fu and Xiao16, Reference Zhou, Peng, Lin, Jiang, Peng and Gu29, Reference Blau, Tella, Taylor and Rother33, Reference Ding, Chen, Yang, Fang, Cao and Liu52]
For diabetics, long-term use is in the minds of 65%, while 27% plan to switch on and off
If youve been following the news around medications like semaglutide (Ozempic, Wegovy) , tirzepatide (Mounjaro, Zepbound) , and the newer retatrutide (still in clinical trials) , youve probably heard about their impressive results
If youre considering starting a GLP-1 or already taking one and struggling with GI symptoms, getting proper medical support can make a meaningful difference